Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Flesher

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Plos Genetics|March 28, 2018
PIKfyve regulates melanosome biogenesisMarc C Liggins, Jessica L Flesher, Sohail Jahid, et al.
Hospital Pediatrics|September 3, 2015
A Quality Improvement Project to Improve Family Recognition of Medical Team Member RolesRebecca M Hayes, Afton Wickline, Christina Hensley, et al.
Blood Advances|June 30, 2019
Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemiaHarry P Erba, Pamela S Becker, Paul J Shami, et al.
Pediatrics|May 15, 2023
Perspectives of Health Care Personnel on the Benefits of Bronchiolitis InterventionsJulia A Marlow, Sonal Kalburgi, Vedant Gupta, et al.
Communications Biology|August 21, 2020
Transcriptomic and proteomic signatures of stemness and differentiation in the colon cryptAmber N Habowski, Jessica L Flesher, Jennifer M Bates, et al.
Communications Biology|September 5, 2020
Publisher Correction: Transcriptomic and proteomic signatures of stemness and differentiation in the colon cryptAmber N Habowski, Jessica L Flesher, Jennifer M Bates, et al.
JCI Insight|June 2, 2022
Multimodal analyses of vitiligo skin identify tissue characteristics of stable diseaseJessica Shiu, Lihua Zhang, Griffin Lentsch, et al.
Cell Reports|April 27, 2022
Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancerSohail Jahid, Jose A Ortega, Linh M Vuong, et al.
Cell Reports|April 6, 2022
Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancerSohail Jahid, Jose A Ortega, Linh M Vuong, et al.
Cell|May 13, 2022
Topical therapy for regression and melanoma prevention of congenital giant neviYeon Sook Choi, Tal H Erlich, Max von Franque, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Plos Genetics|March 28, 2018
PIKfyve regulates melanosome biogenesisMarc C Liggins, Jessica L Flesher, Sohail Jahid, et al.
Hospital Pediatrics|September 3, 2015
A Quality Improvement Project to Improve Family Recognition of Medical Team Member RolesRebecca M Hayes, Afton Wickline, Christina Hensley, et al.
Blood Advances|June 30, 2019
Phase 1b study of the MDM2 inhibitor AMG 232 with or without trametinib in relapsed/refractory acute myeloid leukemiaHarry P Erba, Pamela S Becker, Paul J Shami, et al.
Pediatrics|May 15, 2023
Perspectives of Health Care Personnel on the Benefits of Bronchiolitis InterventionsJulia A Marlow, Sonal Kalburgi, Vedant Gupta, et al.
Communications Biology|August 21, 2020
Transcriptomic and proteomic signatures of stemness and differentiation in the colon cryptAmber N Habowski, Jessica L Flesher, Jennifer M Bates, et al.
Communications Biology|September 5, 2020
Publisher Correction: Transcriptomic and proteomic signatures of stemness and differentiation in the colon cryptAmber N Habowski, Jessica L Flesher, Jennifer M Bates, et al.
JCI Insight|June 2, 2022
Multimodal analyses of vitiligo skin identify tissue characteristics of stable diseaseJessica Shiu, Lihua Zhang, Griffin Lentsch, et al.
Cell Reports|April 27, 2022
Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancerSohail Jahid, Jose A Ortega, Linh M Vuong, et al.
Cell Reports|April 6, 2022
Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancerSohail Jahid, Jose A Ortega, Linh M Vuong, et al.
Cell|May 13, 2022
Topical therapy for regression and melanoma prevention of congenital giant neviYeon Sook Choi, Tal H Erlich, Max von Franque, et al.
Pageof 4